SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coherent (COHR) : Anyone else holding?
COHR 164.04+6.2%10:18 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: appro who wrote (329)11/25/1997 10:24:00 PM
From: Thomas J Pittman  Read Replies (1) of 788
 
Some news on COHR....

S&P has upgraded the stock to their 'platinum
portfolio' which is reserved for stocks which are
both rated '5 stars' and a 'fair value' rating of
5. The 5 stars essentially corrsponds to 'strong
buy' based on their analysts opinions. The fair
value is based on ?someones? assessment of a fair
price for the stock based on what S&P sees as the
fundamentals, expectation for growth, strength of
balance sheet..... and so on. The fair value for
COHR given CURRENT conditions, according to S&P, is
$53. As such, it is seen as significantly off its
fair valuation and earns a 5 and a spot in the
platinum portfolio.

This, of course, from the 'for what its worth'
category.

Regards,

J
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext